UPLOAD Filing
Coya Therapeutics, Inc.
Date: Aug. 13, 2025 · CIK: 0001835022 · Accession: 0000000000-25-008542
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289511
Letter
Re: Coya Therapeutics, Inc. Registration Statement on Form S-3 Filed August 12, 2025 File No. 333-289511 Dear Arun Swaminathan:
August 13, 2025
Arun Swaminathan Chief Executive Officer Coya Therapeutics, Inc. 5850 San Felipe St., Suite 500 Houston, TX 77057
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Daniel C. Porco, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> August 13, 2025 Arun Swaminathan Chief Executive Officer Coya Therapeutics, Inc. 5850 San Felipe St., Suite 500 Houston, TX 77057 Re: Coya Therapeutics, Inc. Registration Statement on Form S-3 Filed August 12, 2025 File No. 333-289511 Dear Arun Swaminathan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Daniel C. Porco, Esq. </TEXT> </DOCUMENT>